CN109833380A - For preventing and treating the composition of eczema - Google Patents
For preventing and treating the composition of eczema Download PDFInfo
- Publication number
- CN109833380A CN109833380A CN201711186941.9A CN201711186941A CN109833380A CN 109833380 A CN109833380 A CN 109833380A CN 201711186941 A CN201711186941 A CN 201711186941A CN 109833380 A CN109833380 A CN 109833380A
- Authority
- CN
- China
- Prior art keywords
- parts
- eczema
- treating
- borneol
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of for preventing and treating the composition of eczema, is made of the Chinese medicine material of following parts by weight: 2-4 parts of litharge, 1-3 parts of borneol, 0.5-1.5 parts of realgar, 1-3 parts of frutus cnidii, 1-3 parts of Cortex Phellodendri, 0.3-1.7 parts of the fruit of summer cypress, 1-5 parts of alumen, 0.5-5.5 parts of field pennycress.The symptom that the eruptive illness such as can be effectively eliminated or greatly alleviate eczema, pruigo in a manner of external therapy can be eliminated the influence of the pathogenies such as hypersensitivity to a certain extent, cure its primary disease, difficulty in relapse after healing of fullying recover from an illness, and curative effect is fast.
Description
[technical field]
The invention belongs to technical field of traditional Chinese medicine, and in particular to a kind of for preventing and treating the composition of eczema.
[background technique]
Eruption refers to that skin occurs being higher by the symptom of the red in skin face or red and white rash point.Mostly because of wind-heat, rheumatism, epidemic disease poison
It invades, accumulates caused by strongly fragrant skin outside Deng evil.It is common in rubeola, morbilli, milk fiber crops, skin disease such as eczema, poisoning of drug, miliaria cancer, scabies, folk song
Sore, universal eczema, pityriasis rose, premenstrual urticaria, rubella during pregnancy etc. and a variety of exogenous disease warm heat diseases such as scarlet fever.Common eruption
There are eczema, pruigo, rubeola etc..Eczema is high dermis and epidermal inflammation caused by a variety of inside and outside factors, is a kind of common
Anaphylaxis, inflammatory dermatoses, symmetrical with fash diversity, violent itch, recurrent exerbation easily evolve into chronic for spy
Sign, is broadly divided into acute eczema, subacute eczema and chronic eczema three classes.The patient of eczema can be such as right there are many intolerance factors
Allergy can also occur for the allergy such as fish, shrimp, beef and mutton, spirits, sucking pollen, dust mite, wool and feather etc..With chronic gall-bladder
Inflammation, gingivitis, tonsillitis, intestinal parasitic disease etc., cold, damp and hot and scratching stimulation etc. can become risk factor.Men and women
Old children can all fall ill, and be more, the obvious seasonality of nothing with native endowment sensitive subjects, but winter usually recurs.Pruigo, i.e. nodositas
Pruigo is a kind of chronic inflammatory skin, characterized by itching and nodositas damage.The cause of disease and insect bites, gastrointestinal function
Disorder, endocrine metabolism obstacle and nervous and mental factors are related.This disease women is common, and skin lesion is apt to occur in four limbs, also seen in waist
Buttocks at most sees shank and stretches side.The pathological change of this disease is non specific chronic inflammation, and epidermis has hyperkeratinization and angling not
Entirely, stratum spinosum epidermidis is plump, and blister can occur for intraepidermal edema, epidermis shallow-layer.Intradermal Mild edema has lymph thin around blood vessel
Born of the same parents' infiltration.Prurigo nodularis pathology epidermis has obvious hyperkeratinization and acanthosis, is in papillomatous hyperplasia, high dermis tissue
Cell, lymphocytic infiltration.From the understanding angle of doctor trained in Western medicine, the specific cause of disease of eczema and pruigo etc. is all indefinite, and pathogenesis is difficult
To accurately hold, therefore, the specific medicament for treating such disease is had no, is generally all only to give antisensitizer, hormone and vitamin C
Deng treatment, and antisensitizer and hormone can all generate apparent toxic side effect to human body, and once be discontinued, and will recur, very then
Rebound, keeps the state of an illness more serious, for example, corticoid drug, can generate dependence, after drug withdrawal primary affection rebound aggravate with
Secondary side effect, often can't bear patient suffering.In addition, the main reason for many Western medicine inherently cause eczema eruption.
In view of above various situations, seek the treatment of traditional Chinese medicine, just seems very urgent.The eruptive disease such as Chinese traditional treatment eczema, pruigo
Suffer from it is with a long history, it is different according to the sent out position of eczema in the historical document of Chinese medicine, and have " acute eczema ", " eczema of the ear ", " four
The appellations such as curved wind ", " skin diseases of the scrota ", " infantile eczema ".In the treatment, either eczema, pruigo or other eruptive illness, are ok
Some card types, then diagnosis and treatment based on an overall analysis of the illness and the patient's condition are summarized according to the etiology and pathogenesis in traditional Chinese medicine.For after all, Chinese medicine thinks eczema, pruigo
It is caused by damp evil, heat evil, ailment said due to cold or exposure, and heresy enters gradually deep, hematozemia impairment of yin, and increases the pathomechanism of blood-deficiency and wind-dry.Clinically,
According to wet, hot, wind three it is evil who it is more who is few, often can the side's of sending medication and take effect;It, also can pointedly prescription as syndrome of wind and dryness due to blood deficiency type
Treatment is controlled.From the above it can be seen that the harm of eczema, pruigo is very big, and doctor trained in Western medicine there is no good plan and the secondary work of the serious poison of Western medicine bring in the treatment
With will cause more bigger problems.
[summary of the invention]
The object of the present invention is to provide a kind of for preventing and treating the composition of eczema, to solve western medical treatment eczema poison
The big defect of side effect.
The invention adopts the following technical scheme: the composition for preventing and treating eczema, by the Chinese medicine of following parts by weight
Raw material is made: 2-4 parts of litharge, 1-3 parts of borneol, and 0.5-1.5 parts of realgar, 1-3 parts of frutus cnidii, 1-3 parts of Cortex Phellodendri, fruit of summer cypress 0.3-
1.7 parts, 1-5 parts of alumen, 0.5-5.5 parts of field pennycress.
Further, it is made of the Chinese medicine material medicine of following parts by weight: 2 parts of litharge, 1 part of borneol, 0.5 part of realgar, snake
1 part of machine tool, 1 part of Cortex Phellodendri, 0.3 part of the fruit of summer cypress, 1 part of alumen, 0.5 part of field pennycress.
Further, it is made of the Chinese medicine material of following parts by weight: 4 parts of litharge, 3 parts of borneol, 1.5 parts of realgar, cnidium monnieri
3 parts, 3 parts of Cortex Phellodendri, 1.7 parts of the fruit of summer cypress, 5 parts of alumen, 5.5 parts of field pennycress of son.
Further, it is made of the Chinese medicine material of following parts by weight: 3 parts of litharge, 2 parts of borneol, 1 part of realgar, frutus cnidii 2
Part, 2 parts of Cortex Phellodendri, 1 part of the fruit of summer cypress, 3 parts of alumen, 3 parts of field pennycress.
Second of technical solution that the present invention uses: for preventing and treating the preparation method of the composition of eczema, specifically
Follow the steps below: step 1 weighs 2-4 parts of litharge respectively by weight, and 1-3 parts of borneol, 0.5-1.5 parts of realgar, snake
1-3 parts of machine tool, 1-3 parts of Cortex Phellodendri, 0.3-1.7 parts of the fruit of summer cypress, 1-5 parts of alumen, 0.5-5.5 parts of field pennycress;Above all medicines be through
It crosses removing impurity and cleans and shine dry-cure;
Step 2 will be sufficiently mixed through the processed above-mentioned drug of step 1, and pulverization adds vinegar to be tuned into paste.
The beneficial effects of the present invention are: can be effectively eliminated in a manner of external therapy or greatly alleviate eczema, pruigo etc. and is eruptive
The symptom of illness can eliminate the influence of the pathogenies such as hypersensitivity to a certain extent, cure its primary disease, be not easy after recovery from illness multiple
Hair, curative effect are fast.
[specific embodiment]
Below by embodiment, technical scheme of the present invention will be described in further detail.
The present invention provides a kind of for preventing and treating the composition of eczema, by the Chinese medicine material system of following parts by weight
At: 2-4 parts of litharge, 1-3 parts of borneol, 0.5-1.5 parts of realgar, 1-3 parts of frutus cnidii, 1-3 parts of Cortex Phellodendri, 0.3-1.7 parts of the fruit of summer cypress,
1-5 parts of alumen, 0.5-5.5 parts of field pennycress.
One, function of each raw material in this drug and major function:
Litharge: a kind of solid drier containing lead oxide enters oil and plays promotion desiccation.
Borneol: through steam distillation and being recrystallized and obtained by composite family Blumea balsamifera cauline leaf or lauraceae plant borneol camphor tree branches and leaves, is used
In sore throat aphtha, it is used for sore swell and ache curative, is not held back after bursting.
Realgar: being being commonly called as Red Arsenic Glass (As4S4), in vitro test is to common pyococcus, pathogenic entero becteria, people
Type, bacillus tuberculosis bovis, the Common Pathogenics dermatophyte such as shame dirt bacillus and achorion violaceum have inhibiting effect.
Frutus cnidii: alias cicely, warm-natured, bitter.Major function: eliminating dampness, wind-dispelling, desinsection, warming kidney and enhancing body.
Cortex Phellodendri: bitter, it is cold in nature.It is clearing heat and detoxicating, purging intense heat eliminating dampness.
The fruit of summer cypress: acrid flavour, hardship, it is cold in nature.Clearing heat and promoting diuresis, dispelling wind and arresting itching.For treating rubeola, eczema, pruitus.
Alumen: matter is hard and crisp, easily smashes, and gas is micro-, slightly sweet and puckery, is used for dissolving phlegm, eliminating dampness, and antidiarrheal is stopped blooding, removing toxic substances.
Field pennycress: cool in nature, acrid flavour, hardship.Major function: clearing heat and detoxicating, removing blood stasis and expelling pus.For carbuncle swells furunculosis.
Two, preparation method and usage and dosage
The present invention is used to prevent and treat the preparation method of the composition of eczema, specifically follows the steps below:
Step 1 weighs 2-4 parts of litharge respectively by weight, and 1-3 parts of borneol, 0.5-1.5 parts of realgar, frutus cnidii 1-3
Part, 1-3 parts of Cortex Phellodendri, 0.3-1.7 parts of the fruit of summer cypress, 1-5 parts of alumen, 0.5-5.5 parts of field pennycress;Above all medicines are miscellaneous by removing
Dry-cure is cleaned and shone to matter;
Step 2 will be sufficiently mixed through the processed above-mentioned drug of step 1, and pulverization adds vinegar to be tuned into paste.
The usage and dosage of the traditional chinese medicine composition of the invention: the used time takes medicine appropriate, embrocates affected part, 3 times a day.
Embodiment 1
Weigh 2 parts of litharge respectively by weight, 1 part of borneol, 0.5 part of realgar, 1 part of frutus cnidii, 1 part of Cortex Phellodendri, the fruit of summer cypress
0.3 part, 1 part of alumen, 0.5 part of field pennycress;Above all medicines are to clean and shine dry-cure by removing impurity;
Step 2 will be sufficiently mixed through the processed above-mentioned drug of step 1, and pulverization adds vinegar to be tuned into paste spare.
Embodiment 2
Weigh 4 parts of litharge respectively by weight, 3 parts of borneol, 1.5 parts of realgar, 3 parts of frutus cnidii, 3 parts of Cortex Phellodendri, the fruit of summer cypress
1.7 parts, 5 parts of alumen, 5.5 parts of field pennycress;Above all medicines are to clean and shine dry-cure by removing impurity;
Step 2 will be sufficiently mixed through the processed above-mentioned drug of step 1, and pulverization adds vinegar to be tuned into paste spare.
Embodiment 3
Weigh 3 parts of litharge respectively by weight, 2 parts of borneol, 1 part of realgar, 2 parts of frutus cnidii, 2 parts of Cortex Phellodendri, the fruit of summer cypress 1
Part, 3 parts of alumen, 3 parts of field pennycress;Above all medicines are to clean and shine dry-cure by removing impurity;
Step 2 will be sufficiently mixed through the processed above-mentioned drug of step 1, and pulverization adds vinegar to be tuned into paste spare.
Embodiment 4
Weigh 2.5 parts of litharge respectively by weight, 1.5 parts of borneol, 0.75 part of realgar, 1.5 parts of frutus cnidii, Cortex Phellodendri 1.5
Part, 0.6 part of the fruit of summer cypress, 2 parts of alumen, 1.7 parts of field pennycress;Above all medicines are to clean and shine dry-cure by removing impurity;
Step 2 will be sufficiently mixed through the processed above-mentioned drug of step 1, and pulverization adds vinegar to be tuned into paste spare.
Three, Clinic Case
Clinic (outpatient service) treatment condition of test example pharmaceutical composition of the present invention, has following symptom features, accepts 52 for medical treatment altogether
Example, wherein eczema 29, pruigo 23.
Affected part is cleaned, the made ointment of Example 1 is applied to affected part, after medicine is slightly dry, is wrapped up, changed daily three times with gauze
Then medicine voluntarily falls off to its drying incrustation and is cured.
It is treatment time, poor according to the difference of the concrete conditions such as each conditions of patients weight, age size, physical strength
Different, generally at 2 weeks to 6 weeks or so, visible obvious effect, one and a half months can terminate to treat, abide by simultaneously to five or six months or so
It is scientifically regulated according to above-mentioned, that is, receives function.
It is specific as follows: to press above-mentioned treatment standard, in 29 eczema patients, there is 10 recoveries from illness, cure rate 34.5%;11
Significant effect accounts for 38%;4 effects are obvious, account for 13.8%;2 have certain effect, account for 6.8%;2 unobvious (nothings of effect
Effect), account for 6.9%.Total effective rate is up to 93.1%.
In 23 pruigo patients, there are 9 recoveries from illness, cure rate 39.2%;8 significant effects, account for 34.8%;2 effects
Obviously, 8.65% is accounted for;2 have certain effect, account for 8.65%;2 effects are unobvious (invalid), account for 8.65%.Total effective rate reaches
91.3%.
In conclusion pharmaceutical composition of the present invention can be effectively eliminated in a manner of external therapy or greatly alleviate eczema, pruigo etc.
The symptom of eruptive illness can eliminate the influence of the pathogenies such as hypersensitivity to a certain extent, cure its primary disease, use to be clinical
Medicine provides a kind of new selection.
Claims (5)
1. the composition for preventing and treating eczema, which is characterized in that be made of the Chinese medicine material of following parts by weight: litharge
2-4 parts, 1-3 parts of borneol, 0.5-1.5 parts of realgar, 1-3 parts of frutus cnidii, 1-3 parts of Cortex Phellodendri, 0.3-1.7 parts of the fruit of summer cypress, alumen 1-5
Part, 0.5-5.5 parts of field pennycress.
2. as described in claim 1 for preventing and treating the composition of eczema, which is characterized in that by following parts by weight
Medicine bulk pharmaceutical chemicals are made: 2 parts of litharge, 1 part of borneol, and 0.5 part of realgar, 1 part of frutus cnidii, 1 part of Cortex Phellodendri, 0.3 part of the fruit of summer cypress, alumen 1
Part, 0.5 part of field pennycress.
3. as described in claim 1 for preventing and treating the composition of eczema, which is characterized in that by following parts by weight
Medicine raw material is made: 4 parts of litharge, 3 parts of borneol, and 1.5 parts of realgar, 3 parts of frutus cnidii, 3 parts of Cortex Phellodendri, 1.7 parts of the fruit of summer cypress, 5 parts of alumen,
5.5 parts of field pennycress.
4. as described in claim 1 for preventing and treating the composition of eczema, which is characterized in that by following parts by weight
Medicine raw material is made: 3 parts of litharge, 2 parts of borneol, and 1 part of realgar, 2 parts of frutus cnidii, 2 parts of Cortex Phellodendri, 1 part of the fruit of summer cypress, 3 parts of alumen, Patrinia scaniosaefolia
3 parts of grass.
5. for preventing and treating the preparation method of the composition of eczema described in a kind of any one of claim 1-4,
It is characterized in that, specifically follows the steps below:
Step 1 weighs 2-4 parts of litharge respectively by weight, 1-3 parts of borneol, 0.5-1.5 parts of realgar, 1-3 parts of frutus cnidii, yellow
1-3 parts of cypress, 0.3-1.7 parts of the fruit of summer cypress, 1-5 parts of alumen, 0.5-5.5 parts of field pennycress;Above all medicines are washed by removing impurity
It is net and solarization dry-cure;
Step 2 will be sufficiently mixed through the processed above-mentioned drug of step 1, and pulverization adds vinegar to be tuned into paste.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711186941.9A CN109833380A (en) | 2017-11-24 | 2017-11-24 | For preventing and treating the composition of eczema |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711186941.9A CN109833380A (en) | 2017-11-24 | 2017-11-24 | For preventing and treating the composition of eczema |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109833380A true CN109833380A (en) | 2019-06-04 |
Family
ID=66875957
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711186941.9A Withdrawn CN109833380A (en) | 2017-11-24 | 2017-11-24 | For preventing and treating the composition of eczema |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109833380A (en) |
-
2017
- 2017-11-24 CN CN201711186941.9A patent/CN109833380A/en not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1325083C (en) | Medicinal composition for removing dampness to relieve itching and its preparation method and uses | |
CN103520572B (en) | A kind of Chinese medicine composition being used for the treatment of atopic dermatitis and preparation method thereof | |
CN108853433A (en) | A kind of Chinese medicine and preparation method thereof for treating diabetic nephropathy | |
CN100348235C (en) | Chinese preparation for treating infantile diarrhea and its making method thereof | |
CN106039109A (en) | Traditional Chinese medicinal liquor for preventing and treating cold dampness accumulation pattern rheumatoid arthritis | |
CN109833380A (en) | For preventing and treating the composition of eczema | |
CN105125814B (en) | It is a kind of to treat chronic renal failure III, the Chinese medicine composition of IV phase | |
CN108743885A (en) | A kind of Chinese medicine and preparation method thereof for treating Diabetic Macrovascular Complications | |
CN106728819A (en) | A kind of medicine and preparation method for treating chronic dermatitis | |
CN114042109B (en) | Traditional Chinese medicine composition and patch for inducing resuscitation and stopping nasal discharge, warming yang and strengthening body resistance and preparation method | |
CN103272079B (en) | A kind of drug compound and application thereof for the treatment of diabetic nephropathy | |
CN105943860A (en) | Medicine preparation for treating diabetes mellitus and preparation method thereof | |
CN101554461B (en) | Medicine for treating psoriasis and preparation method of capsule thereof | |
CN104784567B (en) | A kind of pharmaceutical composition for the treatment of urinary system infection | |
CN104491215B (en) | A kind of Chinese medicine for treating flaccid paralysis | |
CN104523866A (en) | Convulsion and spasm relieving preparation for treating infantile febrile convulsion and preparation method thereof | |
CN103316258B (en) | Medicine composition for treating infantile vaginitis | |
CN103301354B (en) | Preparation method of powder for treating infantile vaginitis | |
CN104083673A (en) | Traditional Chinese medicine composition for treating chronic glomerulonephritis and application of traditional Chinese medicine composition | |
CN103263481B (en) | Chinese medicine composition for curing ulcer and inflammation of digestive system and preparation method of Chinese medicine composition | |
CN117211107A (en) | Traditional Chinese medicine rice paper with physiotherapy effect and preparation method thereof | |
CN117205258A (en) | Traditional Chinese medicine composition for preventing and treating liver injury as well as preparation method and application thereof | |
CN113546131A (en) | Cataplasm patch for treating asthma | |
CN107582792A (en) | A kind of oral traditional Chinese medicine granule and preparation method for treating Child trauma fracture early stage swelling and pain | |
CN105031161A (en) | Nursing liquid for local infection of diabetic foot and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20190604 |